The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 45, doi. 10.3390/pharmaceutics14010045
- By:
- Publication type:
- Article
Works by Zapletalova, Iveta
Results: 11
1
2
in vitro and in silico Studies of Interaction of Synthetic 2,6,9-Trisubstituted Purine Kinase Inhibitors BPA-302, BP-21 and BP-117 With Liver Drug-Metabolizing Cytochromes P450.
- Published in:
- Physiological Research, 2020, v. 69, p. S627, doi. 10.33549/physiolres.934611
- By:
- Publication type:
- Article
3
On the Possible Effect of Phytic Acid (Myo-Inositol Hexaphosphoric Acid, IP6) on Cytochromes P450 and Systems of Xenobiotic Metabolism in Different Hepatic Models.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3610, doi. 10.3390/ijms25073610
- By:
- Publication type:
- Article
4
Effect of DSS-Induced Ulcerative Colitis and Butyrate on the Cytochrome P450 2A5: Contribution of the Microbiome.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11627, doi. 10.3390/ijms231911627
- By:
- Publication type:
- Article
5
In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11513, doi. 10.3390/ijms222111513
- By:
- Publication type:
- Article
6
Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 14, p. 7680, doi. 10.3390/ijms22147680
- By:
- Publication type:
- Article
7
Ovariectomy-Induced Hepatic Lipid and Cytochrome P450 Dysmetabolism Precedes Serum Dyslipidemia.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4527, doi. 10.3390/ijms22094527
- By:
- Publication type:
- Article
8
Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1117683
- By:
- Publication type:
- Article
9
Butyrate Treatment of DSS-Induced Ulcerative Colitis Affects the Hepatic Drug Metabolism in Mice.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.936013
- By:
- Publication type:
- Article
10
The role of the microbiome and psychosocial stress in the expression and activity of drug metabolizing enzymes in mice.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65595-9
- By:
- Publication type:
- Article
11
Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression.
- Published in:
- PLoS ONE, 2021, v. 16, n. 11, p. 1, doi. 10.1371/journal.pone.0259643
- By:
- Publication type:
- Article